Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Italy Cefic Predicts That EU Chemical Output Will Decline in 2008 and 2009Perstorp to Cut 10% of its Workforce in SwedenDSM Divests Deretil to ManagementYara Idles Ammonia, Urea Plants in France; Cuts in the NetherlandsLenzing CFO to Become Chairman Related Stories Lonza and Novartis Jointly to Develop and Manufacture Biologics ProductsEFCG Proposes Certification for Pharma ExcipientsIsrael Chemicals Buys Henkel's Water Treatment BusinessAstraZeneca to Close Three Plants; Cut 1400 Jobs by 2013Perstorp to Buy Solvay’s Caprolactone Business

Regions :: Western Europe :: Italy

September 25, 2008

Lonza in Deal with Crucell for Cell Culture Medium

Deepti Ramesh

Lonza says it has entered into a co-exclusive global manufacturing, sales and distribution agreement with biopharmaceutical company Crucell (Leiden, Netherlands) for Permexcis, a cell culture medium developed by Crucell for PER.C6 cells. According to the...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers